State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Breast (Late Stage^), 2018-2022

All Races (includes Hispanic), Female, All Ages

Sorted by Name

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 42.4 with a 95% confidence interval from 42.3 to 42.5 and 83,714 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 31.0

Alabama²

• Rate : The incidence rate is 39.8 with a 95% confidence interval from 38.7 to 40.8 and 1,247 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (33, 49)
• Percent of Cases with Late Stage : 29.8

Alaska²

• Rate : The incidence rate is 41.6 with a 95% confidence interval from 38.6 to 44.8 and 151 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (3, 50)
• Percent of Cases with Late Stage : 31.0

Arizona²

• Rate : The incidence rate is 37.9 with a 95% confidence interval from 37.0 to 38.7 and 1,630 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (45, 50)
• Percent of Cases with Late Stage : 29.9

Arkansas²

• Rate : The incidence rate is 39.9 with a 95% confidence interval from 38.5 to 41.2 and 727 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (27, 49)
• Percent of Cases with Late Stage : 30.3

California⁷

• Rate : The incidence rate is 41.6 with a 95% confidence interval from 41.2 to 42.0 and 9,285 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (24, 39)
• Percent of Cases with Late Stage : 32.2

Colorado²

• Rate : The incidence rate is 43.0 with a 95% confidence interval from 42.0 to 44.1 and 1,382 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (10, 34)
• Percent of Cases with Late Stage : 31.1

Connecticut⁷

• Rate : The incidence rate is 41.6 with a 95% confidence interval from 40.3 to 42.9 and 948 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (17, 44)
• Percent of Cases with Late Stage : 27.2

Delaware²

• Rate : The incidence rate is 45.1 with a 95% confidence interval from 42.6 to 47.6 and 292 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (1, 35)
• Percent of Cases with Late Stage : 29.3

District of Columbia²

• Rate : The incidence rate is 47.5 with a 95% confidence interval from 44.2 to 50.8 and 169 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 25)
• Percent of Cases with Late Stage : 34.4

Florida²

• Rate : The incidence rate is 43.1 with a 95% confidence interval from 42.6 to 43.6 and 6,141 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (13, 27)
• Percent of Cases with Late Stage : 31.2

Georgia⁷

• Rate : The incidence rate is 47.3 with a 95% confidence interval from 46.5 to 48.1 and 2,945 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 6)
• Percent of Cases with Late Stage : 34.3

Hawaii⁷

• Rate : The incidence rate is 41.4 with a 95% confidence interval from 39.4 to 43.4 and 366 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (11, 48)
• Percent of Cases with Late Stage : 28.4

Idaho⁷

• Rate : The incidence rate is 43.8 with a 95% confidence interval from 42.0 to 45.7 and 450 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (2, 37)
• Percent of Cases with Late Stage : 31.1

Illinois⁷

• Rate : The incidence rate is 45.0 with a 95% confidence interval from 44.3 to 45.7 and 3,439 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (3, 16)
• Percent of Cases with Late Stage : 32.1

Indiana²

• Rate : The incidence rate is 40.8 with a 95% confidence interval from 39.8 to 41.7 and 1,623 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (25, 46)
• Percent of Cases with Late Stage : 30.7

Iowa⁷

• Rate : The incidence rate is 42.8 with a 95% confidence interval from 41.4 to 44.2 and 812 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (9, 40)
• Percent of Cases with Late Stage : 29.9

Kansas²

• Rate : The incidence rate is 43.0 with a 95% confidence interval from 41.6 to 44.5 and 726 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (7, 39)
• Percent of Cases with Late Stage : 30.3

Kentucky⁷

• Rate : The incidence rate is 42.0 with a 95% confidence interval from 40.9 to 43.1 and 1,153 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (15, 42)
• Percent of Cases with Late Stage : 31.0

Louisiana⁷

• Rate : The incidence rate is 46.3 with a 95% confidence interval from 45.2 to 47.5 and 1,286 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 11)
• Percent of Cases with Late Stage : 34.3

Maine²

• Rate : The incidence rate is 40.9 with a 95% confidence interval from 38.9 to 42.9 and 383 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (14, 49)
• Percent of Cases with Late Stage : 28.3

Maryland²

• Rate : The incidence rate is 45.8 with a 95% confidence interval from 44.8 to 46.8 and 1,730 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (1, 13)
• Percent of Cases with Late Stage : 31.9

Massachusetts²

• Rate : The incidence rate is 35.7 with a 95% confidence interval from 34.9 to 36.5 and 1,537 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (50, 51)
• Percent of Cases with Late Stage : 24.7

Michigan²

• Rate : The incidence rate is 41.5 with a 95% confidence interval from 40.7 to 42.2 and 2,565 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (21, 42)
• Percent of Cases with Late Stage : 30.2

Minnesota²

• Rate : The incidence rate is 42.4 with a 95% confidence interval from 41.4 to 43.5 and 1,390 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (13, 39)
• Percent of Cases with Late Stage : 28.5

Mississippi²

• Rate : The incidence rate is 46.2 with a 95% confidence interval from 44.8 to 47.7 and 839 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (1, 14)
• Percent of Cases with Late Stage : 35.8

Missouri²

• Rate : The incidence rate is 45.1 with a 95% confidence interval from 44.1 to 46.1 and 1,695 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (2, 17)
• Percent of Cases with Late Stage : 31.6

Montana²

• Rate : The incidence rate is 43.8 with a 95% confidence interval from 41.4 to 46.3 and 286 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (1, 42)
• Percent of Cases with Late Stage : 30.0

Nebraska²

• Rate : The incidence rate is 41.8 with a 95% confidence interval from 40.1 to 43.7 and 459 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (10, 46)
• Percent of Cases with Late Stage : 31.0

Nevada²

• Rate : The incidence rate is 39.2 with a 95% confidence interval from 37.9 to 40.5 and 709 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (35, 50)
• Percent of Cases with Late Stage : 34.0

New Hampshire²

• Rate : The incidence rate is 40.2 with a 95% confidence interval from 38.2 to 42.2 and 359 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (18, 50)
• Percent of Cases with Late Stage : 26.9

New Jersey⁷

• Rate : The incidence rate is 43.8 with a 95% confidence interval from 43.1 to 44.7 and 2,509 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (8, 23)
• Percent of Cases with Late Stage : 30.7

New Mexico⁷

• Rate : The incidence rate is 38.3 with a 95% confidence interval from 36.7 to 39.9 and 497 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (38, 51)
• Percent of Cases with Late Stage : 31.4

New York⁷

• Rate : The incidence rate is 41.1 with a 95% confidence interval from 40.6 to 41.6 and 5,058 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (27, 43)
• Percent of Cases with Late Stage : 29.2

North Carolina²

• Rate : The incidence rate is 45.6 with a 95% confidence interval from 44.8 to 46.3 and 2,898 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (2, 12)
• Percent of Cases with Late Stage : 30.1

North Dakota²

• Rate : The incidence rate is 39.6 with a 95% confidence interval from 36.7 to 42.5 and 164 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (14, 51)
• Percent of Cases with Late Stage : 29.1

Ohio²

• Rate : The incidence rate is 44.2 with a 95% confidence interval from 43.5 to 44.9 and 3,231 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (6, 21)
• Percent of Cases with Late Stage : 31.8

Oklahoma²

• Rate : The incidence rate is 44.5 with a 95% confidence interval from 43.2 to 45.8 and 1,015 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (3, 24)
• Percent of Cases with Late Stage : 33.6

Oregon²

• Rate : The incidence rate is 39.6 with a 95% confidence interval from 38.5 to 40.8 and 1,029 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (34, 50)
• Percent of Cases with Late Stage : 28.6

Pennsylvania²

• Rate : The incidence rate is 41.7 with a 95% confidence interval from 41.1 to 42.4 and 3,457 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (20, 40)
• Percent of Cases with Late Stage : 30.0

Puerto Rico²

• Rate : The incidence rate is 34.3 with a 95% confidence interval from 33.2 to 35.5 and 798 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 33.1

Rhode Island²

• Rate : The incidence rate is 38.7 with a 95% confidence interval from 36.5 to 41.0 and 263 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (26, 51)
• Percent of Cases with Late Stage : 25.8

South Carolina²

• Rate : The incidence rate is 44.4 with a 95% confidence interval from 43.3 to 45.5 and 1,432 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (4, 23)
• Percent of Cases with Late Stage : 30.9

South Dakota²

• Rate : The incidence rate is 41.4 with a 95% confidence interval from 38.8 to 44.1 and 209 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (6, 50)
• Percent of Cases with Late Stage : 30.3

Tennessee²

• Rate : The incidence rate is 41.8 with a 95% confidence interval from 40.9 to 42.7 and 1,761 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (18, 41)
• Percent of Cases with Late Stage : 31.7

Texas⁷

• Rate : The incidence rate is 41.7 with a 95% confidence interval from 41.3 to 42.2 and 6,447 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (23, 39)
• Percent of Cases with Late Stage : 33.1

Utah⁷

• Rate : The incidence rate is 42.3 with a 95% confidence interval from 40.8 to 43.8 and 630 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (11, 42)
• Percent of Cases with Late Stage : 33.9

Vermont²

• Rate : The incidence rate is 38.3 with a 95% confidence interval from 35.5 to 41.3 and 159 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (21, 51)
• Percent of Cases with Late Stage : 27.1

Virginia²

• Rate : The incidence rate is 41.3 with a 95% confidence interval from 40.5 to 42.1 and 2,135 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (22, 43)
• Percent of Cases with Late Stage : 30.4

Washington¹

• Rate : The incidence rate is 43.9 with a 95% confidence interval from 43.0 to 44.9 and 1,936 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (6, 24)
• Percent of Cases with Late Stage : 30.6

West Virginia²

• Rate : The incidence rate is 42.7 with a 95% confidence interval from 40.9 to 44.5 and 504 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (6, 42)
• Percent of Cases with Late Stage : 31.7

Wisconsin²

• Rate : The incidence rate is 42.7 with a 95% confidence interval from 41.7 to 43.8 and 1,508 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (12, 37)
• Percent of Cases with Late Stage : 29.5

Wyoming²

• Rate : The incidence rate is 44.3 with a 95% confidence interval from 41.0 to 47.8 and 146 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (1, 45)
• Percent of Cases with Late Stage : 33.4

Notes:
Created by statecancerprofiles.cancer.gov on 03/10/2026 12:54 am.

State Cancer Registries may provide more current or more local data.



† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2024 submission.

² Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2024 submission).

⁷ Source: SEER November 2024 submission.

Data for United States does not include Puerto Rico.